OBJECTIVES: New role of pharmacist based on the concept of changing the pharmacist’s focus from drug providing and distributing services to more patient-oriented approaches with positive impact on patient´s quality of life differs regionally.  METHODS: Interregional valuation of patient satisfaction with pharmaceutical care based on previous extended literature research, on studies with psychometrical analysis that focuses on items from Management of therapy (15), Interpersonal relationship (9) and General satisfaction dimension (4). A 5-point Likert scale (from strongly agree (1) – till strongly disagree (5)) was used to measure the patients’ attitudes and expectations with the pharmaceutical care provided in community pharmacies between regions. Essential reasons for visiting the pharmacy and for choosing a particular pharmacy were evaluated either. Descriptive and inferential statistics were used to analyse the data.  The study was conducted in numerous cities of Bratislava region and the rest regions of Slovak republic. RESULTS: Essential reasons for visiting the pharmacy were (Bratislava region/ Rest regions of Slovakia): patient had a recipe (71.5/70.2%), wanted to buy OTC products and food supplements (78.6/69.0%) and other goods (31.1/27.0%) Essential reasons for choosing a particular pharmacy were pharmacy availability (79.3/73.1%); good experience with pharmacy (48.2/49.4%) and pharmacy staff (32.5/32.0%). The best valuated dimension was Interpersonal relationship 62.8/63.1% (mean=16.72/33.5, median=16/16, Std=5.67/5.35, min= 9/9, max=45/44) followed by General satisfaction 58.6/60.0% (mean=8.29/8.05, median=8/8, Std=2.59/2.57, min=4/4, max=20/18). The worst valuated dimension was Management of therapy 53.9/55.3% (mean=34.58/33.5, median=35/34, Std =10.51/10.50, min=15/15, max=75/72). CONCLUSIONS: Interregional valuation of patient satisfaction revealed that patient satisfaction varies from 53.1-63.1% depending on assessed dimension and region. Patient in rest regions of Slovakia are slightly more satisfied with pharmaceutical care in all dimensions. It may mean that patients are already achieving health care services with better quality management  focused on „modern pharmaceutical care“, which may increase their quality of life.